78 related articles for article (PubMed ID: 27894809)
1. Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.
Xiao LY; Kan WM
Eur J Pharmacol; 2017 Jan; 794():201-208. PubMed ID: 27894809
[TBL] [Abstract][Full Text] [Related]
2. Cyclic AMP-induced p53 destabilization is independent of EPAC in pre-B acute lymphoblastic leukemia cells in vitro.
Safa M; Kazemi A; Zaker F; Razmkhah F
J Recept Signal Transduct Res; 2011 Jun; 31(3):256-63. PubMed ID: 21619452
[TBL] [Abstract][Full Text] [Related]
3. Sensitivity of imatinib-resistant T315I BCR-ABL CML to a synergistic combination of ponatinib and forskolin treatment.
Oaxaca DM; Yang-Reid SA; Ross JA; Rodriguez G; Staniswalis JG; Kirken RA
Tumour Biol; 2016 Sep; 37(9):12643-12654. PubMed ID: 27444277
[TBL] [Abstract][Full Text] [Related]
4. Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemia.
Zeng X; Zhao H; Li Y; Fan J; Sun Y; Wang S; Wang Z; Song P; Ju D
Autophagy; 2015; 11(2):355-72. PubMed ID: 25701353
[TBL] [Abstract][Full Text] [Related]
5. Poly ADP-ribose polymerase inhibition suppresses cisplatin toxicity in chronic myeloid leukemia cells.
Xiao LY; Kan WM
Anticancer Drugs; 2017 Mar; 28(3):316-321. PubMed ID: 28207569
[TBL] [Abstract][Full Text] [Related]
6. Cyclic adenosine 5'-monophosphate-stimulated neurotensin secretion is mediated through Rap1 downstream of both Epac and protein kinase A signaling pathways.
Li J; O'Connor KL; Cheng X; Mei FC; Uchida T; Townsend CM; Evers BM
Mol Endocrinol; 2007 Jan; 21(1):159-71. PubMed ID: 17068197
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog signaling regulates Bcr-Abl expression in human chronic myeloid leukemia cells.
Liao HF; Su YC; Zheng ZY; Jhih Cai C; Hou MH; Chao KS; Chen YJ
Biomed Pharmacother; 2012 Jul; 66(5):378-83. PubMed ID: 22397755
[TBL] [Abstract][Full Text] [Related]
8. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
[TBL] [Abstract][Full Text] [Related]
9. Leptin potentiates antiproliferative action of cAMP elevation via protein kinase A down-regulation in breast cancer cells.
Naviglio S; Di Gesto D; Illiano F; Chiosi E; Giordano A; Illiano G; Spina A
J Cell Physiol; 2010 Nov; 225(3):801-9. PubMed ID: 20589829
[TBL] [Abstract][Full Text] [Related]
10. Gap Junction-Mediated Intercellular Communication of cAMP Prevents CDDP-Induced Ototoxicity via cAMP/PKA/CREB Pathway.
Kim YJ; Lee JS; Kim H; Jang JH; Choung YH
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34199197
[TBL] [Abstract][Full Text] [Related]
11. Cyclic adenosine 3',5'-monophosphate, a second messenger in interleukin-1 mediated K562 cytostasis.
Weitzmann MN; Savage N
Biochem Biophys Res Commun; 1993 Jan; 190(2):564-70. PubMed ID: 8381280
[TBL] [Abstract][Full Text] [Related]
12. Cyclic adenosine 3'-5'-monophosphate (cAMP) exerts proliferative and anti-proliferative effects in pituitary cells of different types by activating both cAMP-dependent protein kinase A (PKA) and exchange proteins directly activated by cAMP (Epac).
Vitali E; Peverelli E; Giardino E; Locatelli M; Lasio GB; Beck-Peccoz P; Spada A; Lania AG; Mantovani G
Mol Cell Endocrinol; 2014 Mar; 383(1-2):193-202. PubMed ID: 24373949
[TBL] [Abstract][Full Text] [Related]
13. The opposite effects of cyclic AMP-protein kinase a signal transduction pathway on renal cortical and medullary Na+,K+-ATPase activity.
Bełtowski J; Marciniak A; Wójcicka G; Górny D
J Physiol Pharmacol; 2002 Jun; 53(2):211-31. PubMed ID: 12120897
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
15. Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells.
Puggina E; Sellitti D
Mol Cell Endocrinol; 2004 Apr; 219(1-2):161-9. PubMed ID: 15149737
[TBL] [Abstract][Full Text] [Related]
16. Etoposide and cisplatin induced apoptosis in activated RAW 264.7 macrophages is attenuated by cAMP-induced gene expression.
von Knethen A; Lotero A; Brüne B
Oncogene; 1998 Jul; 17(3):387-94. PubMed ID: 9690520
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a cAMP-dependent protein kinase mutant resistant to cisplatin.
Cvijic ME; Chin KV
Int J Cancer; 1997 Jul; 72(2):345-50. PubMed ID: 9219844
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway.
Li X; Miao H; Zhang Y; Li W; Li Z; Zhou Y; Zhao L; Guo Q
Arch Toxicol; 2015 Jan; 89(1):121-36. PubMed ID: 24671465
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl.
Mc Gee MM; Campiani G; Ramunno A; Fattorusso C; Nacci V; Lawler M; Williams DC; Zisterer DM
J Pharmacol Exp Ther; 2001 Jan; 296(1):31-40. PubMed ID: 11123359
[TBL] [Abstract][Full Text] [Related]
20. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells.
Park SJ; Kim MJ; Kim HB; Sohn HY; Bae JH; Kang CD; Kim SH
Exp Cell Res; 2009 Jul; 315(11):1809-18. PubMed ID: 19268463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
